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Copyright © 200? JCBN Summary It is accepted that pulmonary exposure of rodents to porcine pancreatic elastase
(ELT) induces lesions that morphologically resemble human emphysema. Nonetheless,
extensive analysis of this model has rarely been conducted. The present study was designed to
extensively examine the effects of ELT on lung inflammation, cell damage, emphysematous
change, and cholinergic reactivity in rats. Intratracheal administration of two doses of ELT
induced 1) a proinflammatory response in the lung that was characterized by significant
infiltration of macrophages and an increased level of interleukin-1β in lung homogenates, 2)
lung cell damage as indicated by higher levels of total protein, lactate dehydrogenase, and
alkaline phosphatase (ALP) in lung homogenates, 3) emphysema-related morphological
changes including airspace enlargement and progressive destruction of alveolar wall struc-
tures, and 4) airway responsiveness to methacholine including an augmented Rn value. In
addition, ELT at a high dose was more effective than that at a low dose. This is the novel study
to extensively analyze ELT-induced lung emphysema, and the analysis might be applied to
future investigations that evaluate new therapeutic agents or risk factors for pulmonary
emphysema. In particular, ALP in lung homogenates might be a new biomarker for the
disease progression/exacerbation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is cur-
rently the fourth leading cause of death in the United States,
with up to 7 million patients diagnosed each year [1].
Recently, COPD is also paid to attention as a cause of death
in Japan [2]. Furthermore, it is predicted by the World
Health Organization that the prevalence of COPD will
increase in the coming years to become the fifth most
common cause of morbidity and the third most common
chronic disease worldwide [3]. Patients with COPD have
progressive airflow limitation leading to debilitating dys-
pnea and an inability to properly oxygenate the blood. COPD
is most commonly seen in long-term smokers, and the devel-
opment/progression increases by aging [1,  2]. However,
little is still known about the pathogenesis of the disease.
Emphysema is a major component of COPD and is
characterized by alveolar extracellular matrix destruction,
resulting in airspace enlargement and a reduction in the
alveolar capillary exchange area, which leads to partially
reversible airflow obstruction, which is usually progressive
and associated with an abnormal inflammatory response of
the lung to noxious particles or gases. The proposed patho-
genesis for emphysema development involves a combina-
tion of inflammation, elastase, a matrix metalloprotease
imbalance, apoptosis, and oxidative stress [4]. It is accepted
that pulmonary exposure to porcine pancreatic elastase (ELT),
an enzyme that acts predominantly on elastin [5], elicits acute
lung inflammation [6–8] followed by emphysematous changeExtensive Analysis of Pulmonary Emphysema in Rats
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[9–13] and compromised lung function [14,  15], which
resembles the human disease. However, the characteristics
and appropriate pathobiological biomarkers of this model
have not been fully identified. Furthermore, no extensive
analysis of lung proinflammatory response/damage/histo-
pathological change/functional alteration after several doses
of ELT has ever been conducted, which hampers the
development of an effective therapeutic strategy.
The present study was designed to conduct an extensive
analysis of the effects of two doses of ELT on lung pro-
inflammatory response, cell damage, emphysematous change,
and functional alteration in rats. Simultaneously, we sought
to explore alternate biomarkers for disease progression/
exacerbation.
Materials and Methods
Animals
Nine-week-old SPF F344/DuCrlCrlj (Fischer) male rats
(180–200 g body weight) were purchased from Charles
River Japan (Osaka, Japan) and maintained in conventional
conditions for 3 weeks. They were fed a commercial diet
(CE-2; Japan Clea Co., Tokyo, Japan) and given water ad
libitum. The rats were housed in an animal facility that was
maintained at 22–26°C with 40–69% humidity and a 12-h
light/dark cycle.
Induction of emphysema
The rats were randomly divided into three experimental
groups and received an intratracheal administration of
porcine pancreatic ELT (48.0 U/mg protein; CALBIOCHEM,
EMD Biosciences Inc., CA) at 0, 20, or 160 U dissolved
in 100 μl of Dulbecco’s calcium and magnesium-free
phosphate-buffered saline (PBS; Takara Bio Inc., Shiga,
Japan) under anesthesia with 4% halothane (Takeda Pharma-
ceutical Company, Ltd., Osaka, Japan). Twenty-one days
after the intratracheal administration of ELT, we evaluated
cellularity in bronchoalveolar lavage fluid (BALF), the con-
centrations of proinflammatory mediators and biochemical
parameters in lung homogenates, lung histopathology, and
lung function in the rats. The study protocol followed the
National Institutes of Health guidelines for the experimental
use of animals. All animal studies were approved by the
Institutional Review Board of The National Institute for
Environmental Studies.
Collection of BALF
The rats were anesthetized with sodium pentobarbital
(Kyoritsu Seiyaku Co., Tokyo, Japan) via intraperitoneal
injection (50 mg/kg) and exsanguinated from the abdominal
aorta. A cannula was inserted into the trachea and secured
with a suture. Their lungs were lavaged twice with 10 ml of
sterile saline at 37°C, which was instilled bilaterally by
syringe. The fluid was harvested by gentle aspiration. The
collected fluid was cooled and centrifuged at 300 g for
10 min. Total cell counts were made using a Berker-Tulk
counting chamber. Differential cell counts were assessed
in cytologic preparations. Slides were prepared using an
Autosmear (Sakura Seiki Co., Tokyo, Japan) and were
stained with Diff-Quik (International reagents Co., Kobe,
Japan). A total of 500 cells were counted under oil immer-
sion microscopy (n = 6–8 in each group).
Quantitation of the levels of cytokines, proteins, and
biochemical parameters in the lung tissue supernatants
Lung tissue supernatants were prepared as follows. After
the collection of BALF, the lungs were removed and sub-
sequently homogenized with 10 mM potassium phosphate
buffer (pH 7.4) containing 0.1 mM ethylenediaminetetra-
acetic acid (Sigma, St Louis MO), 0.1 mM phenylmethane-
sulfonyl fluoride (Nacalai Tesque, Kyoto, Japan), 1 μM pep-
statin A (Peptide Institute, Osaka, Japan), and 2 μM
leupeptin (Peptide Institute) as described previously (14).
The homogenates were then centrifuged at 105,000 g for 1 h
at 4°C. Thereafter, the supernatants were stored at −80°C.
Enzyme-linked immunosorbent assays (ELISA) for inter-
leukin (IL)-1β (R&D systems, Minneapolis, MN), IL-4
(R&D systems), IL-6 (R&D systems), IL-13 (Biosource,
Invitrogen, Carlsbad, CA), cytokine-induced neutrophil
chemoattractant (CINC-1: R&D systems), and macrophage
chemoattractant protein (MCP)-1 (Endogen, Pierce Bio-
technology, Rockford, IL) were conducted in the lung tissue
supernatants according to the manufacturer’s instructions.
The detection limits of IL-1β, IL-4, IL-6, IL-13, CINC-1,
and MCP-1 were 5 pg/ml, 5 pg/ml, 21 pg/ml, 1.5 pg/ml,
1.1 pg/ml, and 5 pg/ml, respectively. The total protein level
in the lung tissue supernatants was measured by the Bradford
method using a protein assay kit (BIO-RAD, Hercules, CA).
Biochemical analyses of lactate dehydrogenase (LDH), γ-
glutamyltranspeptidase (GTP), and alkaline phosphatase
(ALP) in the lung tissue supernatants were performed using
kits for LDH (Wako Pure Chemical Industries, Osaka,
Japan), γ-GTP (Daiichi Pure Chemicals, Tokyo, Japan), and
ALP (Wako Pure Chemical Industries).
Lung morphometry
In a separate series of experiments, the rats were anesthe-
tized with sodium pentobarbital via intraperitoneal injection
(50 mg/kg) and exsanguinated from the abdominal aorta.
Both lungs were fixed with 10% buffered formalin infused
through the trachea at a pressure of 20 cm H2O. After sepa-
ration of the lobe, 2-mm thick blocks were taken for paraffin
embedding. Three-micrometer thick sections were stained
with haematoxylin and eosin to observe and evaluate the
degree of infiltration of eosinophils, neutrophils, and mono-
nuclear cells as well as lung structure (n = 6 in each group).K. Inoue et al.
J. Clin. Biochem. Nutr.
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Analysis of lung function
Lung function was measured in open-chested, tracheo-
stomized rats using a computer-controlled small-animal
ventilator (flexiVent; Scireq, Montreal, Canada) as described
previously [16–18]. In brief, the rats were anesthetized with
sodium pentobarbital (40 mg/kg) and xylazine (15 mg/kg,
Bayer HealthCare, Monheim, Germany) via intraperitoneal
injection. The rats had their chests opened and were tracheo-
stomized with a 5 mm section of metallic tubing and venti-
lated at 90 br/min with a tidal volume of 10 ml/kg and a
positive end expiratory pressure of 3 cm H2O.
Both the single-compartment model (using the snapshot
method) and the constant-phase model (using the forced
oscillation technique [FOT] method) of respiratory mechanics
were applied to assess the airway responsiveness and lung
function to methacholine (MCh). For the single-compartment
model, total respiratory system resistance (R), elastance (E),
and compliance (C) were determined. For the constant-phase
model, Newtonian resistance (Rn), tissue damping (G), and
tissue elastance (H) were determined. All data points were
determined by the flexiVent software (version 5.0) by using
multiple linear regressions to fit each data point to the single-
compartment or the constant-phase model, as appropriate.
The lung volume history of the mice was standardized prior
to the measurement of lung mechanics using two deep infla-
tions. After 5 min of regular mechanical ventilation, a sine
wave perturbation was applied three times, and the mean
was calculated to generate a baseline measurement. The
respiratory system input impedance was measured during
periods of apnea using a 3 s signal containing 19 mutually
prime sinusoidal frequencies ranging from 0.25 to 19.625 Hz.
These maneuvers generated data that were fitted to the
single-compartment or the constant-phase compartment
models, respectively. The means of these measurements for
each mouse served as their baseline values. Following the
acquisition of baseline data, airway responsiveness to
aerosolized MCh (6.25 to 50 mg/mL; Tokyo Chemical
Industry, Tokyo, Japan), delivered by an ultrasonic nebulizer,
was assessed using both the snapshot and FOT methods. The
aerosols were delivered for 10 s with ventilation at 90 br/
min and a tidal volume of 3 ml/kg, after which the snapshot
and FOT methods were applied consecutively every 6 s for
Fig. 1. Cellularity in BALF after intratracheal challenge. BALF from each rat were collected 21 days after the intratracheal administra-
tion of ELT. Total cell counts were performed using a Berker-Tulk counting chamber. Differential cell counts were assessed in
cytologic preparations stained with Diff-Quik. The results are means ± SEM (n = 6–8 in each group). (a) total cells, (b) macro-
phages, (c) neutrophils, (d) monocytes. **p<0.01 vs the sham group.Extensive Analysis of Pulmonary Emphysema in Rats
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5 min. Peak responses during each 5-min period were
determined, and only values with a coefficient of determina-
tion of 0.95 or greater were used (n = 10–12 in each group).
Statistical analysis
Data are shown as the mean ± SEM. The significance of
differences among groups were determined using ANOVA
with Dunnett’s test (Stat view version 5.0; Abacus Concepts
Inc., Berkeley, CA). Values of p<0.05 were considered
significant.
Results
The effects of ELT on airway inflammation
We examined the cellular profile in BALF 21 days after
the intratracheal administration (Fig. 1). ELT increased the
total number of cells and macrophages and tended to
increase the numbers of neutrophils and monocytes as
compared to the sham group (p<0.01 for total cells and
macrophages in the ELT (160 U) group). ELT at a high dose
was more effective than that at a low dose.
The effects of ELT on cytokine expression in the lung
We examined the levels of proinflammatory cytokines
Fig. 2. Cytokine and chemokine profiles in the lung after intratracheal challenge. Lung tissue samples of each rat were harvested 21
days after the intratracheal administration of ELT. The levels of IL-1β (a), IL-4 (b), IL-6 (c), IL-13 (d), CINC-1 (e), and MCP-1
(f) in the lung tissue supernatants were measured by ELISA. The results are means ± SEM (n = 6–8 in each group). **p<0.01 vs
the sham group.K. Inoue et al.
J. Clin. Biochem. Nutr.
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and chemokines in lung tissue homogenates 21 days after
the intratracheal administration of ELT (Fig. 2). ELT
increased the level of IL-1β and tended to increase the level
of IL-6 compared with the sham treatment (p<0.01 for IL-1β
in ELT (160 U) group). ELT at a high dose was more
effective than that at a low dose. The levels of the other
cytokines were not altered by ELT treatment.
The effects of ELT on lung cell damage
We examined the levels of total protein, LDH, γ-GTP,
and ALP in the lung tissue homogenates 21 days after the
intratracheal administration of ELT (Fig. 3). ELT increased
the levels of total protein, ALP, and LDH compared with the
sham treatment (p<0.01 for total protein in the ELT 160 U
group and LDH in the ELT 20 U and 160 U groups; p<0.05
for ALP in the ELT 160 U group). ELT at a high dose was
more effective than that at a low dose. The level of γ-GTP
was low and was not altered by ELT treatment.
The effects of ELT on lung morphological changes
We evaluated lung specimens that had been stained with
hematoxylin and eosin 21 days after the intratracheal
administration of ELT (Fig. 4). No pathological changes
were seen in the lung specimens obtained from the sham
group. On the other hand, pathologic findings such as air-
space enlargement and progressive destruction of alveolar
wall structures were evident in the ELT-treated rats. ELT at a
high dose was more effective than that at a low dose.
The effects of ELT on lung function
To evaluate the effects of ELT on lung function including
responsiveness to Mch, we investigated R, E, C, Rn, G, and
H 21 days after the intratracheal administration of ELT
(Fig. 5). R, E, Rn, G, and H tended to be enhanced by ELT as
compared to the sham treatment, although the enhancement
did not reach statistical significance. ELT at a high dose was
more effective than that at a low dose. C was not altered by
ELT treatment.
Discussion
The present study has shown that intratracheal administra-
tion of ELT to rats induces/enhances 1) lung proinflammatory
response, 2) lung cell damage, 3) emphysema–related lung
morphological changes, and 4) airway responsiveness to
MCh. This is the comprehensive study to extensively analyze
an ELT-induced lung emphysema model.
Intratracheal administration of ELT reportedly induces
Fig. 3. The levels of total protein, LDH, γ-GTP, and ALP in the lung after intratracheal challenge with ELT. The lung tissue samples of
each rat were harvested 21 days after the intratracheal administration of ELT. The levels of total protein (a) LDH (b), γ-GTP (c),
and ALP (d) in the lung tissue supernatants were measured. The results are means ± SEM (n = 6–8 in each group). *p<0.05
versus the sham group, **p<0.01 vs the sham group.Extensive Analysis of Pulmonary Emphysema in Rats
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acute lung inflammation [3, 6–8] followed by devastating
emphysema [9–13] and compromised lung function [14, 15].
However, there have been few studies that have performed a
comprehensive analysis of the above-mentioned parameters
[3]. Thus, the first aim of this study was to characterize in
detail the effects of ELT on proinflammatory response,
damage, emphysematous change, and function including
cholinergic hyperresponsiveness in the lung. As a result, we
found an overall positive correlation among lung inflam-
matory response, emphysematous change, and cholinergic
airway hyperresponsiveness. Previous reports have shown
similar correlations [19,  20]. However, there are several
differences between our study and the studies of others with
respect to animal species/strains and ELT dose. Specifically,
the mechanics and measuring methods for lung function
were different. In the previous reports, lung function was
only evaluated via the enhanced pause (Penh) index, which
is measured using whole-body plethysmography. Penh does
not measure lung mechanics directly. On the other hand, we
evaluated lung function in open-chested rats that had
received a tracheostomy on a flexiVent mechanical venti-
lator. Furthermore, Bellofiore’s and Scuri’s groups did not
perform BAL or examine the lung expression of proinflam-
matory cytokines so as to strictly correlate lung inflamma-
tion with cholinergic airway hyperresponsiveness [19, 20].
Taken together, our study is novel in that performs a
comprehensive analysis of ELT-induced emphysema in rats
to examine/correlate lung inflammation/damage/structural
change/function simultaneously. However, it is assumed that
additional studies using larger number of rats are needed to
ascertain which of these effects are significant.
The mechanisms by which ELT dose-dependently tends
to enhance airway responsiveness to MCh remains unclear.
By using the same emphysema model, Scuri et al. have
shown that ELT causes bronchoconstriction possibly via a
bradykinin-dependent pathway [20]. On the other hand,
neutrophil elastase can induce airway smooth muscle cell
proliferation  in vitro [ 21]. In addition, IL-1β reportedly
affects bronchoconstriction in asthmatic subjects [22, 23]. In
the present study, IL-1β was increased in lung tissue homo-
genates by ELT and was linked to pathological structural
changes and augmented cholinergic airway hyperrespon-
siveness. Furthermore, the increase was more effective at a
high dose of ELT than at a low dose. Therefore, it can be
proposed that ELT tended to enhance cholinergic airway
reactivity through 1) bradykinin-dependent pathway, 2) pro-
moted smooth muscle cell proliferation, 3) IL-1β-mediated
pathway, and so on. Nevertheless, it should be clarified by
additional research whether ELT significantly enhances
airway reactivity against MCh and which mechanisms
underlie the phenomenon.
Another aim of the current study was to explore a new
biomarker for disease progression/exacerbation in the
model. Pauluhn et al. [24, 25] implicated escaped enzymes
in BALF in early pulmonary responses to chemical (poly-
meric  diphenylmethane-4,4'-diisocyanate)-induced toxicity.
Additionally, Cobben et al. [26] suggested that LDH activity
in BALF is a diagnostic tool for infectious lung diseases.
Fig. 4. Microscopic findings in the lung after intratracheal
challenge with ELT. Histologic changes in the lung of
each rat were evaluated 21 days after the intratracheal
administration of ELT. The sections were stained with
hematoxylin and eosin, and histologic analyses were
performed using a microscope (bar: 100 μm). (a) Sham
group, (b) ELT 20 U group, (c) ELT 160 U group.K. Inoue et al.
J. Clin. Biochem. Nutr.
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In the respiratory system, ALP is a marker for assessing the
degree of pneumocyte type II cell stimulation, differentia-
tion, and damage [25–27], and LDH is a marker of general
cytotoxicity [25], and its elevation is associated with several
pulmonary disorders [28]. However, as far as we have
searched in Medline database, there are no reports that have
measured these enzymes in an in vivo emphysema model.
In the present study, we first demonstrated that activity of
these two enzymes is elevated in lung homogenates by ELT.
The elevation was more effective at a high dose of ELT than
that at a low dose, which parallels the lung proinflammatory
response and emphysematous change. Furthermore, previous
studies [24, 25, 29] examined these levels only in BALF.
Taken together, we suggest that LDH and ALP in lung
tissue homogenates are candidates for new biomarkers of
disease progression/deterioration in pulmonary emphysema.
Moreover, the present results raise the possibility that this
assay could be applied to other pathological pulmonary
conditions in which epithelial damage is a central feature of
the pathogenesis, e.g. acute lung injury, pulmonary fibrosis,
viral pneumonia, particulate matters-induced lung toxicity,
and so on.
In summary, the present extensive analysis has shown that
intratracheal administration of ELT induces/enhances lung
Fig. 5. Dose response curve of inhaled MCh after intratracheal challenge with ELT. Airway responsiveness/lung function to MCh,
were measured by a flexiVent 21 days after the intratracheal administration of ELT. The parameters of R (a), E (b), and C (c)
were measured by fitting the linear single-compartment model (using the snapshot method). The parameters of Rn (d), G (e),
and H (f) were measured by fitting the constant phase model (using the FOT method). Data are shown as means ± SEM
(n = 10–12 in each group).Extensive Analysis of Pulmonary Emphysema in Rats
Vol. 46, No. 2, 2010
175
proinflammatory response, lung cell damage, emphysema-
related lung morphological changes, and airway responsive-
ness to MCh. In addition, ELT is more effective at a higher
dose. This is the novel study to examine ELT-induced
pulmonary emphysema in a extensive manner in order to
correlate these parameters, and this analysis might be
applied to future evaluations of new therapeutic agents or
risk factors, although additional research is required. In
particular, ALP in lung homogenates might be an alternative
biomarker for disease progression/exacerbation.
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